Delivery Order SPE2DB22D9239-SPE2DB23FDL88
Award Date 8/10/23
Potential Completion Date 8/31/23
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562251945 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The start date is September 18, 2023 and the end date is October 10, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procurement and distribution of medical supplies and pharmaceuticals. This delivery order provides Kadcyla, a breast...
- The Defense Logistics Agency awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561740665 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 4, 2023 through August 25, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and services to enable military readiness and operations. This delivery order provides cancer treatment...
- The Defense Logistics Agency awarded a $7,891.36 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from July 10, 2023 through July 31, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and services to fulfill military operations. This delivery order provides cancer treatment pharmaceuticals for...
- The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561695383 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from August 2, 2023 through August 23, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support and supplies in support of various DOD...
- The Defense Logistics Agency awarded a $23,674 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562251946 KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois. The order period of performance is from September 18, 2023 through October 10, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for the cancer treatment drug Kadcyla supports the Agency's mission to provide...
- The Defense Logistics Agency awarded a $23,674 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561822907 KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois, with work scheduled to be completed by August 31, 2023 under a start date of August 10, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order for the cancer treatment drug Kadcyla supports the Agency's mission...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-three thousand six hundred seventy-four dollars and eight cents ($23,674.08) to DMS Pharmaceutical Group Incorporated. The order is for one hundred sixty (160) milligrams of Kadcyla vials to be delivered to a location in Park Ridge, Illinois by October thirteenth, twenty twenty-three. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to provide medical...
- The Defense Logistics Agency awarded a $51,256.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4561727282 units of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 3, 2023 through August 24, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the Department of Defense, this delivery order is likely providing cancer treatment drugs to military treatment...
- The Defense Logistics Agency awarded a $39,456.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4562070724 units of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 30, 2023 through September 21, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts and supply chain management as one of the largest logistics combat support agencies within the federal...
- <p>The Defense Logistics Agency awarded a $24,614.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561488997 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The start date is July 11, 2023 and the end date is August 1, 2023. The Defense Logistics Agency supports Department of Defense programs by procuring pharmaceuticals and medical supplies. No subcontractors or set aside designations were indicated.</p>
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDL88Delivery Order
The Defense Logistics Agency awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561822914 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The start date is August 10, 2023 and the end date is August 31, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and services to support military readiness and operations. This delivery order provides Kadcyla, a breast cancer drug, in support of the Agency's mission to ensure medical supplies are available for military treatment facilities and personnel.
Generated 12/15/23, 2:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 8/10/23 |